Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 7/20 | 0.74 |
| ▸ | CA1 | P00915 | 2/20 | 0.74 |
| ▸ | CA4 | P22748 | 2/20 | 0.74 |
| ▸ | CA6 | P23280 | 2/20 | 0.74 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.74 |
| ▸ | CA2 | P00918 | 1/20 | 0.74 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.74 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.74 |
| ▸ | ITGAL | P20701 | 1/20 | 0.74 |
| ▸ | ADK | P55263 | 1/20 | 0.74 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indole SCHEMBL11402854 | 0.89 | AHR (0.77) | AHRCA1CA4CA6TRPA1 | |
| Indole SCHEMBL27500374 | 0.88 | AHR (0.68) | AHRCA1CA4CA6TRPA1 | |
| Indole SCHEMBL30042337 | 0.87 | AHR (0.74) | AHRCA1CA4CA6TRPA1 | |
| Indole SCHEMBL21723436 | 0.87 | AHR (0.74) | AHRCA1CA4CA6TRPA1 | |
| Indole SCHEMBL20819817 | 0.87 | AHR (0.74) | AHRCA1CA4CA6TRPA1 | |
| Indole SCHEMBL27679207 | 0.87 | AHR (0.74) | AHRCA1CA4CA6TRPA1 | |
| Indole SCHEMBL28241238 | 0.87 | AHR (0.74) | AHRCA1CA4CA6TRPA1 | |
| Indole SCHEMBL27957692 | 0.86 | AHR (0.90) | AHRCA1CA4CA6TRPA1 | |
| Indole SCHEMBL30463845 | 0.86 | — | — | |
| Indole SCHEMBL30250492 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250324977-A1 | ENGINEERED BACTERIA FOR ENHANCED CROP PRODUCTION | UNIV CALIFORNIA (US) | 2025-10-23 | — | — | US | claimed |
| WO-2023235512-A2 | ENGINEERED BACTERIA FOR ENHANCED CROP PRODUCTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-12-07 | — | — | WO | claimed |
| CN-114487416-A | Intracranial aneurysm-related plasma metabolism markers and application thereof | 南方医科大学珠江医院 | 2022-05-13 | — | — | CN | claimed |
| CN-109234245-B | Indole acetaldehyde dehydrogenase gene ald2 and overexpression and application thereof | 南京农业大学 | 2022-04-22 | — | — | CN | claimed |
| CN-1207569-C | Method for assaying virus-containing sample, virus assaying method and diagnostic kit | ADVANCED LIFE SCIENCE INST INC (JP) | 2005-06-22 | — | — | CN | claimed |
| CN-1239548-A | Method for detecting or determining viruses | TONEN CORP (JP) | 1999-12-22 | — | — | CN | claimed |
| US-20250324977-A1 | ENGINEERED BACTERIA FOR ENHANCED CROP PRODUCTION | UNIV CALIFORNIA (US) | 2025-10-23 | — | — | US | disclosed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| WO-2024229110-A1 | INDOLE LACTATE FOR THE TREATMENT OF MULTIPLE SCLEROSIS | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-11-07 | — | — | WO | disclosed |
| US-20240110192-A1 | BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER | SYNLOGIC OPERATING COMPANY, INC. (US) | 2024-04-04 | — | — | US | disclosed |
| WO-2024058984-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |
| EP-3164495-B1 | MICROORGANISMS FOR PRODUCING 4C-5C COMPOUNDS WITH UNSATURATION AND METHODS RELATED THERETO | GENOMATICA INC (US) | 2024-02-28 | — | — | EP | disclosed |
| US-11896627-B2 | Bacteria engineered to treat metabolic diseases | SYNLOGIC OPERATING COMPANY, INC. (US) | 2024-02-13 | — | — | US | disclosed |
| US-20010044381-A1 | Aspartic acid derivative-containing compositions and use thereof in stimulating and/or regulating plant and plant precursor growth | LIDOCHEM INC. | 2001-11-22 | — | — | US | disclosed |
| US-6245717-B1 | APPLYING 4-PHENYLBUTYRIC ACID TO IMPROVE CROP YIELD | COMPASS BANK | 2001-06-12 | — | — | US | disclosed |
| US-6239073-B1 | CYCLOPENTYL-SUBSTITUTED BRASSINOSTEROIDS HAVING HIGH GROWTH PROMOTING ABILITY | EXELIXIS PLANT SCIENCES, INC. | 2001-05-29 | — | — | US | disclosed |
| WO-2000058338-A1 | BRASSINOSTEROID ANALOGS USEFUL AS PLANT GROWTH REGULATORS | AGRITOPE, INC. (US) | 2000-10-05 | — | — | WO | disclosed |
| US-6063731-A | COMPOUNDS WHICH PROMOTE PLANT GROWTH | AGRITOPE, INC. (US) | 2000-05-16 | — | — | US | disclosed |
| CN-1239548-A | Method for detecting or determining viruses | TONEN CORP (JP) | 1999-12-22 | — | — | CN | disclosed |
| EP-0506532-A1 | Indole derivatives, process for their preparation and medicaments containing them | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1992-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240110192-A1 | BACTERIA ENGINEERED TO TREAT DISEASES THAT BENEFIT FROM REDUCED GUT INFLAMMATION AND/OR TIGHTENED GUT MUCOSAL BARRIER | FABP2, TLR9, LY96 | AHR 416/4885CA1 3282/4885CA4 1675/4885 |
| US-11896627-B2 | Bacteria engineered to treat metabolic diseases | GOT2, BPGM, MLYCD | AHR 985/4885CA1 4844/4885CA4 3435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.